A detailed history of Jennison Associates LLC transactions in Insmed Inc stock. As of the latest transaction made, Jennison Associates LLC holds 744,280 shares of INSM stock, worth $55.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
744,280
Previous 118,512 528.02%
Holding current value
$55.5 Million
Previous $3.22 Million 1451.04%
% of portfolio
0.03%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$22.0 - $69.71 $13.8 Million - $43.6 Million
625,768 Added 528.02%
744,280 $49.9 Million
Q1 2024

May 02, 2024

SELL
$25.72 - $29.94 $59,644 - $69,430
-2,319 Reduced 1.92%
118,512 $3.22 Million
Q4 2023

Feb 01, 2024

BUY
$23.42 - $31.74 $2.83 Million - $3.84 Million
120,831 New
120,831 $3.74 Million
Q4 2017

Jan 25, 2018

SELL
$26.43 - $31.78 $39.8 Million - $47.9 Million
-1,506,142 Closed
0 $0
Q3 2017

Nov 03, 2017

BUY
$11.61 - $31.21 $17.5 Million - $47 Million
1,506,142
1,506,142 $47 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10.1B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.